Market Forecasts and Industry Analysis Global Atenolol Market Outlook 2016-2021

Atenolol Market Overview 2016-2021 By
Radiant Insights, Inc
“This report provides detailed analysis of worldwide
markets for Atenolol from 2011-2015 and provides
extensive market forecasts 2016-2021 by
region/country and subsectors.”
Atenolol is a selective ?1 receptor antagonist, a drug belonging to the group of beta blockers
(sometimes written ?-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced
in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It
works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not
readily pass through the blood-brain barrier, thus decreasing the incidence of central nervous system
side effects.
Atenolol is one of the most widely used ?-blockers in the United Kingdom and was once the first-line
treatment for hypertension. However, recent studies indicate that atenolol may not reduce morbidity
or mortality when used to treat hypertension, and may even increase mortality in some subgroups. In
addition, the role for ?-blockers in general in hypertension was downgraded in June 2006 in the
United Kingdom, and later in the United States, as they are less appropriate than newer drugs,
particularly in the elderly.
Complete Report Available @ http://www.radiantinsights.com/research/global-atenolol-
market-outlook-2016-2021
Follow Us: